Filtered By:
Drug: Rituxan
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 5482 results found since Jan 2013.
Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4068 patients
Haematologica. 2023 Aug 31. doi: 10.3324/haematol.2023.283446. Online ahead of print.ABSTRACTPrimary mediastinal B-cell lymphoma (PMBCL) is a distinct clinicopathologic entity. Currently, there is a paucity of randomized prospective data to inform on optimal frontline chemoimmunotherapy (CIT) and use of consolidative mediastinal radiation (RT). To assess if distinct CIT approaches are associated with disparate survival outcomes, we performed a systematic review and meta-analysis comparing dose-intensive (DI-CIT) versus standard CIT for the frontline treatment of PMBCL. Standard approach (S-CIT) was defined as R-CHOP-21/CHO...
Source: Haematologica - August 30, 2023 Category: Hematology Authors: Michael R Cook Lacey S Williams Charles Scott Dorris Yutong Luo Kepher Makambi Kieron Dunleavy Source Type: research
Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: case report
CONCLUSIONS: This report highlights the safety and effectiveness of BTK inhibitors, as well as lenalidomide and PD-1 inhibitor in HIV-related PCNSL patients. Both the new therapeutic approaches and a multidisciplinary team authentically contributed to improved survival outcome among HIV-positive PCNSL patients.PMID:37644480 | PMC:PMC10466696 | DOI:10.1186/s12981-023-00554-8
Source: AIDS Research and Therapy - August 29, 2023 Category: Infectious Diseases Authors: Ying Zhou Xiaoxue Wang Xuyong Lin Jun Wang Xiaojing Yan Ying Wen Source Type: research
Hepatitis B virus-related cryoglobulinemia: Clinical characteristics, virological features, and treatment
CONCLUSIONS: HBV-related cryoglobulinemia patients should be treated with antiviral therapy. Corticosteroids and rituximab are effective for severe cases, but patients need to be closely monitored for therapy-related infection.PMID:37640269 | DOI:10.1016/j.virusres.2023.199212
Source: Virus Research - August 28, 2023 Category: Virology Authors: Hong-Xiao Han Wei Su Dao-Bin Zhou Jian Li Xin-Xin Cao Source Type: research
Hepatitis B Virus-Related Cryoglobulinemia: Clinical Characteristics, Virological Features, and Treatment
CONCLUSIONS: HBV-related cryoglobulinemia patients should be treated with antiviral therapy. Corticosteroids and rituximab are effective for severe cases, but patients need to be closely monitored for therapy-related infection.PMID:37640269 | DOI:10.1016/j.virusres.2023.199212
Source: Virus Research - August 28, 2023 Category: Virology Authors: Hong-Xiao Han Wei Su Dao-Bin Zhou Jian Li Xin-Xin Cao Source Type: research
Hepatitis B virus-related cryoglobulinemia: Clinical characteristics, virological features, and treatment
CONCLUSIONS: HBV-related cryoglobulinemia patients should be treated with antiviral therapy. Corticosteroids and rituximab are effective for severe cases, but patients need to be closely monitored for therapy-related infection.PMID:37640269 | DOI:10.1016/j.virusres.2023.199212
Source: Virus Research - August 28, 2023 Category: Virology Authors: Hong-Xiao Han Wei Su Dao-Bin Zhou Jian Li Xin-Xin Cao Source Type: research
A human immune system (HIS) mouse model that dissociates roles for mouse and human FcR+ cells during antibody-mediated immune responses
This article is protected by copyright. All rights reserved.PMID:37621208 | DOI:10.1002/eji.202350454
Source: European Journal of Immunology - August 25, 2023 Category: Allergy & Immunology Authors: Anna Louisa Thaller Friederike J önsson Oriane Fiquet Solenne Marie Jean-Marc Doisne Giulia Girelli-Zubani Toshiki Eri Priyanka Fernandes Evgeny Tatirovsky Francina Langa-Vives Pierre Bruhns H élène Strick-Marchand James P Di Santo Source Type: research
